Korean Janssen and Johnson & Johnson Innovation Host 'Seoul Innovation Quickfire Challenge'

[Asia Economy Reporter Lee Gwan-joo] Johnson & Johnson Innovation and Korea Janssen announced on the 8th that they are launching the 'Seoul Innovation QuickFire Challenge: Scientific Advancements of Tomorrow' in collaboration with the Seoul Metropolitan Government and the Korea Health Industry Development Institute.

This contest invites innovators worldwide, including individuals, companies, academia, biotechnologists, and startups, to submit innovative ideas or technologies for scientific advancement in various key areas such as oncology, immunology, infectious diseases, neuroscience, cardiovascular and metabolic diseases, retinal diseases, pulmonary hypertension, and vision.

Winners will receive up to 150 million KRW in funding, a 2-year residency at Seoul Bio Hub, a 1-year usage right for a dedicated workstation at Shanghai JLABS, and access to Johnson & Johnson Innovation infrastructure and mentorship opportunities in the Asia-Pacific region.

Melinda Richter, Global Head of Johnson & Johnson Innovation JLABS, said, “We are pleased to conduct this challenge with the Seoul Metropolitan Government and the Korea Health Industry Development Institute to address unmet medical needs within Seoul’s rapidly growing biomedical ecosystem. This year, innovators with diverse strengths ranging from cell therapy to next-generation biosensors can apply for opportunities to utilize infrastructure not only in Korea but across the Asia-Pacific region.”

This content was produced with the assistance of AI translation services.